131 - Systematic Review of Therapy Used in Higher-Risk (HR) Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)
| Autor: | Bell, J., Galaznik, A., Huelin, R., Stokes, M., Seal, B., Fram, R., Faller, D.V. |
|---|---|
| Zdroj: | In Leukemia Research April 2017 55 Supplement 1:S80-S81 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect